Myomo (MYO) Gains from Investment Securities (2016 - 2024)
Myomo (MYO) reported Gains from Investment Securities of $68160.0 for Q4 2024, up 307.07% quarter-over-quarter from $16744.0 in Q2 2023.
Myomo (MYO) Gains from Investment Securities (2016 - 2024) Analysis & Trends
Myomo has reported Gains from Investment Securities for 9 years, with the latest figure at $68160.0 in Q4 2024.
- For the quarter ending Q4 2024, Gains from Investment Securities changed N/A year-over-year to $68160.0; the trailing twelve-month figure through Dec 2024 stood at $19148.0 (down 88.76% YoY), and the FY2024 full-year result was $23194.0, down 5.44% from the prior year.
- Gains from Investment Securities for Q4 2024 stood at $68160.0, up from $16744.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $654091.0 in Q4 2021, with the low at -$49012.0 in Q1 2023.
- Historically, Gains from Investment Securities has averaged $91733.8 across 5 years, with a median of $4032.0 in 2022.
- Annual changes were most pronounced in 2021 — Gains from Investment Securities soared 28220.85% — and 2023, when it sank 870.14%.
- Myomo's Gains from Investment Securities stood at -$2326.0 in 2020, then soared by 28220.85% to $654091.0 in 2021, then plunged by 66.47% to $219301.0 in 2022, then slumped by 92.36% to $16744.0 in 2023, then soared by 307.07% to $68160.0 in 2024.
- The last three Gains from Investment Securities figures came in at $68160.0 (Q4 2024), $16744.0 (Q2 2023), and -$49012.0 (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Myomo | 49.44 Mn | 31.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 68,160.00 |
| Dec 31, 2024 | 68,160.00 |
| Jun 30, 2023 | 16,744.00 |
| Jun 30, 2023 | 16,744.00 |
| Mar 31, 2023 | -49,012.00 |
| Mar 31, 2023 | -49,012.00 |
| Dec 31, 2022 | 219,301.00 |
| Dec 31, 2022 | 219,301.00 |
| Sep 30, 2022 | 1,700.00 |
| Sep 30, 2022 | 1,700.00 |
| Jun 30, 2022 | 1,700.00 |
| Jun 30, 2022 | 1,700.00 |
| Mar 31, 2022 | 6,364.00 |
| Mar 31, 2022 | 6,364.00 |
| Dec 31, 2021 | 654,091.00 |
| Dec 31, 2021 | 654,091.00 |
| Mar 31, 2021 | 616.00 |
| Mar 31, 2021 | 616.00 |
| Dec 31, 2020 | -2,326.00 |
| Dec 31, 2020 | -2,326.00 |